Cargando…
Specific knockdown of Htra2 by CRISPR-CasRx prevents acquired sensorineural hearing loss in mice
CasRx, a recently discovered member of the type VI CRISPR system with minimum size, offers a new approach for RNA manipulation with high efficiency and specificity in prokaryotes and eukaryotes. However, in vivo studies of functional recovery using the CasRx system have not been well characterized....
Autores principales: | Guo, Yang, Han, Lei, Han, Shuang, Tang, Honghai, Wang, Shengyi, Cui, Chong, Chen, Bing, Li, Huawei, Shu, Yilai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112053/ https://www.ncbi.nlm.nih.gov/pubmed/35615000 http://dx.doi.org/10.1016/j.omtn.2022.04.014 |
Ejemplares similares
-
Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing
por: Zheng, Ziwen, et al.
Publicado: (2022) -
Methods for in vitro CRISPR/CasRx-Mediated RNA Editing
por: Chuang, Yu-Fan, et al.
Publicado: (2021) -
CRISPR/CasRx-Mediated RNA Knockdown Reveals That ACE2 Is Involved in the Regulation of Oligodendroglial Cell Morphological Differentiation
por: Kato, Yukino, et al.
Publicado: (2022) -
Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme
por: Zhan, Yonghao, et al.
Publicado: (2023) -
Programmable RNA Targeting Using CasRx in Flies
por: Buchman, Anna B., et al.
Publicado: (2020)